Article
The hypomorphic TERT A1062T variant is associated with increased treatment-related toxicity in acute myeloid leukemia.
Annals of hematology - 1 Jun 2017
Both Anna, Krauter Jürgen, Damm Frederik, Thol Felicitas, Göhring Gudrun, Heuser Michael, Ottmann Oliver, Lübbert Michael, Wattad Mohammed, Kanz Lothar, Schlimok Günter, Raghavachar Aruna, Fiedler Walter, Kirchner Hartmut, Brugger Wolfram, Schlegelberger Brigitte, Heil Gerhard, Ganser Arnold, Wagner Katharina
Abstract excerpt
Hypomorphic germline variants in TERT, the gene encoding the reverse transcriptase component of the human telomerase complex, occur with a frequency of 3-5% in acute myeloid leukemia. We analyzed the clinical and prognostic impact of the most common TERT A1062T variant in younger patients with acute myeloid leukemia intensively treated within two prospective multicenter trials. Four hundred and twenty patients...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
